Johns Hopkins Medicine Feb 2 2026 Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage cancers by measuring the random variation in DNA methylation patterns, rather than the absolute level of those patterns as in other liquid biopsies. The method, which utilizes a new metric called the Epigenetic Instability Index (EII), successfully distinguished - with high accuracy - patients with early-stage lung and breast cancers from

Tag-uri: DNA